Cordyceps Sunshine Biotech Holdings (RAJAF) Total Liabilities (2020 - 2025)

Cordyceps Sunshine Biotech Holdings' Total Liabilities history runs 6 years deep, the most recent figure standing at $5.2 million for Q4 2025.

• In Q4 2025, Total Liabilities rose 3.86% year-over-year to $5.2 million; the TTM figure through Dec 2025 stood at $5.2 million (up 3.86% YoY), while the FY2025 annual figure was $5.2 million, up 3.86% from the prior year.
• Total Liabilities was $5.2 million for Q4 2025 at Cordyceps Sunshine Biotech Holdings, up from $5.0 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $5.2 million in Q4 2025 to a low of $2.0 million in Q3 2023.
• Historically, Total Liabilities has averaged $3.7 million across 5 years, with a median of $3.5 million in 2021.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities slipped 13.64% in 2022, then soared 42.69% in 2024.
• A 5-year view of Total Liabilities shows it stood at $3.5 million in 2021, then retreated by 13.64% to $3.1 million in 2022, then grew by 14.64% to $3.5 million in 2023, then jumped by 42.69% to $5.0 million in 2024, then grew by 3.86% to $5.2 million in 2025.
• The last three Total Liabilities figures came in at $5.2 million (Q4 2025), $5.0 million (Q4 2024), and $3.5 million (Q4 2023), per Business Quant data.